Target Audience: This activity is designed for physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists and the healthcare team. This activity is accredited for physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists and the healthcare team.
Module Description: Provides an overview of the history of opioid use with an overview of contributing factors to the current epidemic. Using clinical cases, opioid use disorder is then discussed in detail. Finally, there is a discussion of harm reduction approaches and treatment options.
Educational Objectives:
- Analyze the pharmaceutical marketing practices and iatrogenic factors that have contributed to the current opioid epidemic.
- Evaluate risk factors for opioid use disorder (OUD) in patients prescribed opioid medications and integrate this knowledge into clinical practice.
- Detect behavioral red flags that may indicate opioid misuse.
- Implement harm reduction strategies for effective overdose prevention.
Accreditation Statement
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
Physicians
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Nurse Practitioners
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credit.
Pharmacists
This activity has been approved for 1 hour of pharmacy continuing education credit for each module. The approval numbers issued are Universal Activity Numbers (pharmacy): Module 1) JA4008192-0000-24-064-H01-P; Module 2) JA4008192-0000-24-065-H01-P; Module 3) JA4008192-0000-24-066-H01-P; and Module 4) JA4008192-0000-24-067-H01-P.
PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until November 15, 2027. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.
All Learners
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.
